OncLive SOSS

Patient Profiles in HER2-Positive Breast Cancer - Episode 12

Patient Profile 1: Trastuzumab Deruxtecan for HER2+ Metastatic BC

May 19, 2022

Shanu Modi, MD, Rena D. Callahan, MD, Tiffany A. Traina, MD, Sara M. Tolaney, MD, MPH

Expert perspectives on the use of trastuzumab deruxtecan in a patient with HER2+ metastatic breast cancer.

EP. 1: HER2+ Breast Cancer: Overview of the Treatment Armamentarium

EP. 2: Selecting and Sequencing Therapy for HER2+ Breast Cancer

EP. 3: Recent Trial Data in HER2+ Metastatic Breast Cancer

EP. 4: Patient Profile 1: Frontline Therapy for HER2+ mBC

EP. 5: Patient Profile 1: Second-Line Therapy for HER2+ mBC

EP. 6: Patient Profile 1: Sequencing Therapies in HER2+ mBC

EP. 7: Patient Profile 2: Patient with Triple-Positive mBC

EP. 8: Patient Profile 2: Second-Line Therapy for Triple-Positive mBC

EP. 9: Patient Profile 2: 3L Therapy for Triple-Positive mBC

EP. 10: Considering Novel Therapy for HER2+ Metastatic Breast Cancer

EP. 11: Patient Profile 1: 62-Year-Old Woman With Metastatic Breast Cancer

EP. 12: Patient Profile 1: Trastuzumab Deruxtecan for HER2+ Metastatic BC

EP. 13: Patient Profile 2: 26-Year-Old Woman With Triple Positive Breast Cancer

EP. 14: Patient Profile 2: Strategies for Managing Brain Metastases in HER2+ Metastatic Breast Cancer

EP. 15: Patient Profile 2: How Should T-DM1 Be Sequenced in HER2+ mBC?

EP. 16: Patient Profile 2: Clinical Utility of the HER2CLIMB Regimen for HER2+ mBC

EP. 17: Patient Profile 2: Treatment Sequencing in a Patient with Progressive Brain Metastases

EP. 18: Patient Profile 3: 43-Year-Old Woman With Metastatic Breast Cancer Progressing Through Multiple Lines of Therapy

EP. 19: Patient Profile 3: Treatment Sequencing in a Patient with metastatic HER2+ Breast Cancer

EP. 20: Patient Profile 4: Strategies for Managing ILD in Patients Receiving Trastuzumab Deruxtecan

EP. 21: Patient Profile 4: Managing AEs in Patients Receiving Treatment for HER2+ BC

EP. 22: Patient Profile 5: Strategies for Managing Elevated Liver Function Tests in Patients on the HER2CLIMB Regimen

EP. 23: Future Directions in the Management of HER2+ Breast Cancer